1
|
Economopoulos KP, Ward NL, Phillips CD, Teshager A, Patel P, Mohamed MM, Hakimian S, Cox SB, Ahmed R, Moaven O, Kaliannan K, Alam SN, Haller JF, Goldstein AM, Bhan AK, Malo MS, Hodin RA. Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase. Diabetes Obes Metab 2016; 18:519-27. [PMID: 26876427 PMCID: PMC5110215 DOI: 10.1111/dom.12645] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/10/2015] [Revised: 02/02/2016] [Accepted: 02/09/2016] [Indexed: 12/20/2022]
Abstract
AIMS To examine whether co-administration of intestinal alkaline phosphatase (IAP) with antibiotics early in life may have a preventive role against metabolic syndrome (MetS) in mice. METHODS A total of 50 mice were allocated to four treatment groups after weaning. Mice were treated with azithromycin (AZT) ± IAP, or with no AZT ± IAP, for three intermittent 7-day cycles. After the last treatment course, the mice were administered a regular chow diet for 5 weeks and subsequently a high-fat diet for 5 weeks. Body weight, food intake, water intake, serum lipids, glucose levels and liver lipids were compared. 16S rRNA gene pyrosequencing was used to determine the differences in microbiome composition. RESULTS Exposure to AZT early in life rendered mice susceptible to MetS in adulthood. Co-administration of IAP with AZT completely prevented this susceptibility by decreasing total body weight, serum lipids, glucose levels and liver lipids to the levels of control mice. These effects of IAP probably occur as a result of changes in the composition of specific bacterial taxa at the genus and species levels (e.g. members of Anaeroplasma and Parabacteroides). CONCLUSIONS Co-administration of IAP with AZT early in life prevents mice from susceptibility to the later development of MetS. This effect is associated with alterations in the composition of the gut microbiota. IAP may represent a novel treatment against MetS in humans.
Collapse
Affiliation(s)
- K. P. Economopoulos
- Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - N. L. Ward
- Departments of Molecular Biology and Botany, University of Wyoming, WY 82071, USA
| | - C. D. Phillips
- Research and Testing Laboratory, Lubbock, TX 79407
- Department of Biological Sciences, Texas Tech University, Lubbock, TX 79409
| | - A. Teshager
- Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - P. Patel
- Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - M. M. Mohamed
- Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - S. Hakimian
- Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - S. B. Cox
- Research and Testing Laboratory, Lubbock, TX 79407
| | - R. Ahmed
- Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - O. Moaven
- Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - K. Kaliannan
- Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - S. N. Alam
- Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - J. F. Haller
- Lipid Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - A. M. Goldstein
- Department of Pediatric Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - A. K. Bhan
- Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - M. S. Malo
- Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - R. A. Hodin
- Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
- Corresponding author: Richard A. Hodin, MD, Department of Surgery, Massachusetts General Hospital, 15 Parkman Street, Boston, MA 02114; Telephone: (617) 724-2570; Fax: (617) 724-2574;
| |
Collapse
|
2
|
Economopoulos K, Van Der Wilden G, Teshager A, Hakimian S, Muhammad N, Tantillo T, Mohamed M, Gul S, Hamarneh S, Karas A, Tao Q, Morrison S, Malo M, Fagenholz P, Hodin R. Perioperative Fasting Reduces Intestinal Alkaline Phosphatase in Humans. J Surg Res 2014. [DOI: 10.1016/j.jss.2013.11.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
3
|
Mohamed M, Hamarneh S, Patel P, Malo N, Kalliannan K, Teshager A, Raychowdhury A, Moss A, Muhammad N, Abtahi S, Moaven O, Alam S, Economopoulos K, Malo M, Hodin R. Intestinal Alkaline Phosphatase is an Endogenous Anti-Inflammatory Factor. J Surg Res 2013. [DOI: 10.1016/j.jss.2012.10.593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
4
|
Hamarneh S, Kalliannan K, Mohamed M, Teshager A, Patel P, Malo N, Abtahi S, Muhammad N, Moaven O, Raychowdhury A, Alam S, Economopoulos K, Bhan A, Malo M, Hodin R. Intestinal Alkaline Phosphatase Prevents Acute Alcohol-Induced Liver Injury. J Surg Res 2013. [DOI: 10.1016/j.jss.2012.10.427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|